Tg Therapeutics (TGTX) Interest Coverage Ratio (2011 - 2026)

Tg Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 4.54 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 255.71% year-over-year to 4.54; the TTM figure through Mar 2026 stood at 5.41 (up 158.87% YoY), while the FY2025 annual figure was 4.61, up 164.42% from the prior year.
• Interest Coverage Ratio was 4.54 for Q1 2026 at Tg Therapeutics, down from 7.73 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 30.91 in Q3 2023 to a low of 27.09 in Q4 2022.
• Historically, Interest Coverage Ratio has averaged 3.92 across 5 years, with a median of 1.15 in 2024.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 96.29% in 2024, then jumped 280.62% in 2025.
• A 5-year view of Interest Coverage Ratio shows it stood at 27.09 in 2022, then soared by 53.88% to 12.49 in 2023, then soared by 133.95% to 4.24 in 2024, then jumped by 82.23% to 7.73 in 2025, then sank by 41.28% to 4.54 in 2026.
• The last three Interest Coverage Ratio figures came in at 4.54 (Q1 2026), 7.73 (Q4 2025), and 4.37 (Q3 2025), per Business Quant data.